294620-60-3 Usage
General Description
4-(2-Methyl-1,3-thiazol-4-yl)benzoic acid is a chemical compound with the molecular formula C11H9NO2S. It is a white to off-white crystalline powder that is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 4-(2-METHYL-1,3-THIAZOL-4-YL)BENZOIC ACID has a thiazole ring and a benzoic acid group, and it is commonly used as a building block in organic synthesis. It has properties that make it suitable for use in drug discovery and development, and it is also used as a reagent in chemical research and analysis. This chemical is generally stable under normal conditions, but it should be handled and stored following standard safety precautions.
Check Digit Verification of cas no
The CAS Registry Mumber 294620-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,4,6,2 and 0 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 294620-60:
(8*2)+(7*9)+(6*4)+(5*6)+(4*2)+(3*0)+(2*6)+(1*0)=153
153 % 10 = 3
So 294620-60-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H9NO2S/c1-7-12-10(6-15-7)8-2-4-9(5-3-8)11(13)14/h2-6H,1H3,(H,13,14)
294620-60-3Relevant articles and documents
Uncovering an allosteric mode of action for a selective inhibitor of human bloom syndrome protein
Chen, Xiangrong,Ali, Yusuf I.,Fisher, Charlotte EL,Arribas-Bosacoma, Raquel,Rajasekaran, Mohan B.,Williams, Gareth,Walker, Sarah,Booth, Jessica R.,Hudson, Jessica JR,Mark Roe,Pearl, Laurence H.,Ward, Simon E.,Pearl, Frances MG,Oliver, Antony W.
, (2021/04/02)
BLM (Bloom syndrome protein) is a RECQ-family helicase involved in the dissolution of complex DNA structures and repair intermediates. Synthetic lethality analysis implicates BLM as a promising target in a range of cancers with defects in the DNA damage r
Benzamide nitriles
-
Page 35-36, (2010/02/09)
Compounds of the formula (I) wherein m, n, A, R1, R2, R3, R4, R5 and R6 are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.
